Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol. 2011 Oct; 6(10):2499-507.
View in:
PubMed
subject areas
Adolescent
Adult
Antidiuretic Hormone Receptor Antagonists
Benzazepines
Disease Progression
Female
Glomerular Filtration Rate
Hormone Antagonists
Humans
Japan
Kidney
Male
Middle Aged
North America
Polycystic Kidney, Autosomal Dominant
Prospective Studies
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Arlene Chapman